Advisornet Financial’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $142K | Sell |
368
-253
| -41% | -$93.8K | 0.01% | 750 |
|
|
2026
Q1 | $182K | Sell |
621
-329
| -35% | -$108K | 0.01% | 643 |
|
|
2025
Q4 | $333K | Buy |
950
+25
| +3% | +$8.45K | 0.02% | 477 |
|
|
2025
Q3 | $299K | Buy |
925
+270
| +41% | +$84K | 0.02% | 495 |
|
|
2025
Q2 | $255K | Sell |
655
-1
| -0.2% | -$402 | 0.02% | 516 |
|
|
2025
Q1 | $285K | Sell |
656
-4
| -0.6% | -$1.61K | 0.02% | 463 |
|
|
2024
Q4 | $243K | Sell |
660
-6
| -0.9% | -$2.51K | 0.02% | 465 |
|
|
2024
Q3 | $346K | Buy |
666
+143
| +27% | +$76.4K | 0.03% | 401 |
|
|
2024
Q2 | $283K | Buy |
523
+5
| +1% | +$2.64K | 0.03% | 411 |
|
|
2024
Q1 | $269K | Sell |
518
-14
| -3% | -$6.96K | 0.03% | 416 |
|
|
2023
Q4 | $251K | Buy |
532
+16
| +3% | +$7.4K | 0.02% | 433 |
|
|
2023
Q3 | $225K | Sell |
516
-72
| -12% | -$32.7K | 0.02% | 433 |
|
|
2023
Q2 | $261K | Sell |
588
-7
| -1% | -$3.23K | 0.02% | 430 |
|
|
2023
Q1 | $274K | Sell |
595
-29
| -5% | -$13.8K | 0.03% | 412 |
|
|
2022
Q4 | $320K | Buy |
624
+23
| +4% | +$11.7K | 0.03% | 377 |
|
|
2022
Q3 | $273K | Buy |
601
+21
| +4% | +$10K | 0.03% | 439 |
|
|
2022
Q2 | $280K | Buy |
580
+61
| +12% | +$30.2K | 0.03% | 433 |
|
|
2022
Q1 | $255K | Buy |
519
+17
| +3% | +$7.77K | 0.02% | 499 |
|
|
2021
Q4 | $233K | Sell |
502
-32
| -6% | -$13.5K | 0.01% | 569 |
|
|
2021
Q3 | $199K | Buy |
534
+134
| +34% | +$50.9K | 0.01% | 584 |
|
|
2021
Q2 | $153K | Hold |
400
| – | – | 0.01% | 670 |
|
|
2021
Q1 | $144K | Sell |
400
-60
| -13% | -$19.3K | 0.01% | 649 |
|
|
2020
Q4 | $148K | Sell |
460
-82
| -15% | -$25.2K | 0.01% | 579 |
|
|
2020
Q3 | $146K | Buy |
542
+82
| +18% | +$22.1K | 0.01% | 571 |
|
|
2020
Q2 | $121K | Hold |
460
| – | – | 0.01% | 619 |
|
|
2020
Q1 | $104K | Hold |
460
| – | – | 0.01% | 605 |
|
|
2019
Q4 | $139K | Hold |
460
| – | – | 0.01% | 595 |
|
|
2019
Q3 | $110K | Hold |
460
| – | – | 0.01% | 650 |
|
|
2019
Q2 | $130K | Buy |
460
+60
| +15% | +$16.4K | 0.01% | 536 |
|
|
2019
Q1 | $115K | Sell |
400
-190
| -32% | -$55K | 0.01% | 524 |
|
|
2018
Q4 | $155K | Sell |
590
-75
| -11% | -$20.6K | 0.02% | 432 |
|
|
2018
Q3 | $182K | Sell |
665
-11
| -2% | -$2.86K | 0.02% | 433 |
|
|
2018
Q2 | $161K | Sell |
676
-39
| -5% | -$9.03K | 0.02% | 436 |
|
|
2018
Q1 | $157K | Sell |
715
-135
| -16% | -$31.7K | 0.02% | 436 |
|
|
2017
Q4 | $191K | Buy |
+850
| New | +$181K | 0.03% | 358 |
|
Other funds holding ELV
LMFP
HGIM
DC
CF
MIHAS
Advisornet Financial's ELV Position: Q2 2026 in Review
Advisornet Financial reduced its Elevance Health (ELV) stake by 41% in Q2 2026, selling an estimated $93.8K and leaving 368 shares worth $142K. The position accounts for 0.01% of the portfolio, ranked #750.
Advisornet Financial first reported a position in ELV in Q4 2017 and has held it in 35 quarters since. The position peaked at $346K in Q3 2024. 348 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Advisornet Financial held 368 shares of Elevance Health worth $142K as of Q2 2026.
- Advisornet Financial sold 253 Elevance Health shares in Q2 2026, an estimated $93.8K.
- Elevance Health made up 0.01% of Advisornet Financial's portfolio in Q2 2026, its #750 holding.
- Advisornet Financial first reported a position in Elevance Health in Q4 2017 and has held it in 35 quarters since.
- Advisornet Financial's Elevance Health position peaked at $346K in Q3 2024.
- 348 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Advisornet Financial's 13F filing for Q2 2026, filed 23 Jul 2026.